Elixir Capital [ELIXIR] vs Authum Investment [AIIL] Detailed Stock Comparison

Elixir Capital
BSE
Loading...

Authum Investment
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Elixir Capital wins in 10 metrics, Authum Investment wins in 9 metrics, with 0 ties. Elixir Capital appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Elixir Capital | Authum Investment | Better |
---|---|---|---|
P/E Ratio (TTM) | 6.73 | 12.03 | Elixir Capital |
Price-to-Book Ratio | 1.11 | 3.34 | Elixir Capital |
Debt-to-Equity Ratio | 41.68 | 7.18 | Authum Investment |
PEG Ratio | N/A | -0.86 | N/A |
EV/EBITDA | 2.36 | 11.54 | Elixir Capital |
Profit Margin (TTM) | 27.32% | 93.88% | Authum Investment |
Operating Margin (TTM) | 238.25% | 96.55% | Elixir Capital |
EBITDA Margin (TTM) | 238.25% | 96.55% | Elixir Capital |
Return on Equity | 17.07% | 28.87% | Authum Investment |
Return on Assets (TTM) | 11.93% | 26.36% | Authum Investment |
Free Cash Flow (TTM) | $11.30M | $-2.59B | Elixir Capital |
Dividend Yield | 1.13% | 0.06% | Elixir Capital |
1-Year Return | -8.11% | 108.78% | Authum Investment |
Price-to-Sales Ratio (TTM) | 1.84 | 11.30 | Elixir Capital |
Enterprise Value | $493.07M | $499.01B | Authum Investment |
EV/Revenue Ratio | 1.44 | 11.46 | Elixir Capital |
Gross Profit Margin (TTM) | 218.30% | 97.25% | Elixir Capital |
Revenue per Share (TTM) | $59 | $256 | Authum Investment |
Earnings per Share (Diluted) | $16.07 | $240.80 | Authum Investment |
Beta (Stock Volatility) | -0.06 | -0.68 | Authum Investment |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Elixir Capital vs Authum Investment Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Elixir Capital | -0.65% | -5.91% | -5.09% | -16.87% | -43.54% | -67.26% |
Authum Investment | 3.10% | 1.02% | 10.91% | 35.69% | 76.43% | 53.59% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Elixir Capital | -8.11% | 140.44% | 283.69% | 96.01% | 183.25% | 569.97% |
Authum Investment | 108.78% | 239.27% | 239.27% | 239.27% | 239.27% | 239.27% |
Performance & Financial Health Analysis: Elixir Capital vs Authum Investment
Metric | ELIXIR | AIIL |
---|---|---|
Market Information | ||
Market Cap | ₹627.91M | ₹492.16B |
Market Cap Category | Small cap | Large cap |
10 Day Avg. Volume | 1,767 | 251,255 |
90 Day Avg. Volume | 2,065 | 369,604 |
Last Close | ₹107.50 | ₹2,987.40 |
52 Week Range | ₹104.00 - ₹351.05 | ₹1,325.50 - ₹3,021.00 |
% from 52W High | -69.38% | -1.11% |
All-Time High | ₹351.05 (Dec 23, 2024) | ₹3,021.00 (Aug 18, 2025) |
% from All-Time High | -69.38% | -1.11% |
Growth Metrics | ||
Quarterly Revenue Growth | -1.68% | -0.15% |
Quarterly Earnings Growth | N/A | -0.14% |
Financial Health | ||
Profit Margin (TTM) | 0.27% | 0.94% |
Operating Margin (TTM) | 2.38% | 0.97% |
Return on Equity (TTM) | 0.17% | 0.29% |
Debt to Equity (MRQ) | 41.68 | 7.18 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹97.83 | ₹866.73 |
Cash per Share (MRQ) | ₹120.41 | ₹21.74 |
Operating Cash Flow (TTM) | ₹20.03M | ₹20.13B |
Levered Free Cash Flow (TTM) | ₹93.27M | ₹42.41B |
Dividends | ||
Last 12-Month Dividend Yield | 1.13% | 0.06% |
Last 12-Month Dividend | ₹1.25 | ₹1.50 |
Valuation & Enterprise Metrics Analysis: Elixir Capital vs Authum Investment
Metric | ELIXIR | AIIL |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 6.73 | 12.03 |
Forward P/E | N/A | N/A |
PEG Ratio | N/A | -0.86 |
Price to Sales (TTM) | 1.84 | 11.30 |
Price to Book (MRQ) | 1.11 | 3.34 |
Market Capitalization | ||
Market Capitalization | ₹627.91M | ₹492.16B |
Enterprise Value | ₹493.07M | ₹499.01B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.44 | 11.46 |
Enterprise to EBITDA | 2.36 | 11.54 |
Risk & Other Metrics | ||
Beta | -0.06 | -0.68 |
Book Value per Share (MRQ) | ₹97.83 | ₹866.73 |
Financial Statements Comparison: Elixir Capital vs Authum Investment
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | ELIXIR | AIIL |
---|---|---|
Revenue/Sales | ₹-40.50M | ₹12.15B |
Cost of Goods Sold | ₹47.91M | ₹334.70M |
Gross Profit | ₹-88.41M | ₹11.82B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹-98.14M | ₹11.34B |
EBITDA | ₹-93.67M | ₹11.37B |
Pre-Tax Income | ₹-103.22M | ₹11.44B |
Income Tax | ₹-18.83M | ₹2.01B |
Net Income (Profit) | ₹-84.39M | ₹9.43B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | ELIXIR | AIIL |
---|---|---|
Cash & Equivalents | ₹108.76M | ₹1.08B |
Total Current Assets | ₹839.09M | ₹25.77B |
Total Current Liabilities | ₹357.15M | ₹678.10M |
Long-Term Debt | N/A | ₹10.24B |
Total Shareholders Equity | ₹798.70M | ₹146.89B |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | ₹18.24M | N/A |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | ELIXIR | AIIL |
---|---|---|
Operating Cash Flow | ₹30.93M | N/A |
Capital Expenditures | ₹857,890 | N/A |
Free Cash Flow | ₹-3.79M | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | ELIXIR | AIIL |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 1,767 | 251,255 |
Average Daily Volume (90 Day) | 2,065 | 369,604 |
Shares Outstanding | 5.80M | 169.85M |
Float Shares | 854,289 | 29.26M |
% Held by Insiders | 0.83% | 0.87% |
% Held by Institutions | 0.00% | 0.02% |
Dividend Analysis & Yield Comparison: Elixir Capital vs Authum Investment
Metric | ELIXIR | AIIL |
---|---|---|
Last 12-Month Dividend | ₹1.25 | ₹1.50 |
Last 12-Month Dividend Yield | 1.13% | 0.06% |
3-Year Avg Annual Dividend | ₹1.67 | ₹0.50 |
3-Year Avg Dividend Yield | 2.35% | 0.04% |
3-Year Total Dividends | ₹5.00 | ₹1.50 |
Ex-Dividend Date | Aug 16, 2024 | May 16, 2025 |